Treatment with glimepiride, but not mitiglinide and short-acting insulin, resists body weight and abdominal fat reduction under dietary energy restriction.
Nakano
Takanari
T
Inoue
Ikuo
I
Satoh
Kentaro
K
Yamazaki
Mochihito
M
Awata
Takuya
T
Kurihara
Susumu
S
Goto
Sei-ichi
S
Shinoda
Yu-ichi
Y
Komoda
Tsugikazu
T
Katayama
Shigehiro
S
D050153:Abdominal Fat / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D004038:Diet, Reducing; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D054833:Isoindoles / Q000494:pharmacology* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use*
D007328:Insulin; D054833:Isoindoles; D013453:Sulfonylurea Compounds; C057619:glimepiride; C087255:mitiglinide